Related Experiment Video
Updated: Jul 15, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
Published on: February 13, 2016
A critical review of gastric retentive controlled drug delivery
1Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340, USA. ken.waterman@pfizer.com
Abstract:
The promise of gastric retentive drug delivery systems has propagated numerous investigations and the formation of a number of companies. Three technologies have involved a substantial number of human clinical trials: mucoadhesion, density modification, and expansion. Standard, nondisintegrating controlled-release tablets can display significant gastric retention times, with that retention time being proportional to the calorie intake. When these data for standard tablets are factored in, gastric retention technologies do not appear to offer significant additional retention times. Although the goal remains valuable, the promise of gastric retentive drug delivery systems remains unfulfilled at this time.
Related Concept Videos
Oral Drug Delivery Systems: Continuous-Release Systems
Oral Drug Delivery Systems: Delayed-Release Systems
Modified-Release Drug Delivery Systems: Overview
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Drug Delivery: Enteral Route
Drugs in...
Modified-Release Drug Delivery Systems: Classification

